Literature DB >> 1324064

The effect of pertussis toxin on beta-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure.

L A Brown1, S E Harding.   

Abstract

1. A decreased responsiveness to the positive inotropic effects of beta-adrenoceptor agonists is a characteristic of human heart failure. We have investigated the involvement of inhibitory guanine nucleotide binding proteins (G-proteins) in this process using pertussis toxin treatment of isolated cardiac myocytes. 2. Myocytes isolated from failing human myocardium had a reduced maximum contractile response to isoprenaline relative to that for maximally stimulating concentrations of calcium, giving an isoprenaline/calcium ratio of 0.71 +/- 0.06 (n = 7 patients). This was significantly lower than in myocytes from non-failing myocardium, where the isoprenaline/calcium ratio was 1.16 +/- 0.07 (n = 6, P less than 0.001). Responses to high calcium were unchanged. 3. Myocytes were treated with pertussis toxin for 3-5 h at 35 degrees C. Successful inactivation of inhibitory G-proteins by pertussis toxin treatment was indicated by a loss of responsiveness to 10 microM adenosine (in the presence of submaximal isoprenaline). 4. Following pertussis toxin treatment of the myocytes from failing human heart the isoprenaline/calcium ratio increased to 1.43 +/- 0.27 (n = 7, P less than 0.05). Pertussis toxin treatment had no effect upon the maximum calcium contraction. The isoprenaline/calcium ratio in myocytes from non-failing human ventricle was not affected by the toxin treatment (n = 3). These observations support the hypothesis that increased inhibitory G-protein levels or activities contribute to beta-adrenoceptor desensitization in human heart failure. 5. beta-Adrenoceptor desensitization in human heart failure is thought to be secondary to raised noradrenaline levels in these patients. Experiments were repeated on myocytes isolated from hearts of guinea-pigs which had been chronically infused with noradrenaline. The isoprenaline/calcium ratio of these myocytes was reduced below that of myocytes from sham-operated animals (0.65 0.04, n = 6 compared with 0.88 +/- 0.02, n = 7, P<0.001).6. Pertussis toxin treatment (2 h at 35 degrees C) increased the isoprenaline/calcium ratio to 1.02 0.02 (n = 6,P<0.01) in myocytes from noradrenaline-treated guinea-pigs. This effect of pertussis toxin treatment was not seen in myocytes from sham-operated guinea-pig hearts.7. Incubation at 35 degrees C for similar periods in the absence of pertussis toxin also restored the isoprenaline/calcium ratio towards normal in the myocytes from both failing human and noradrenaline-treated guinea-pig hearts, although the effect was significantly smaller than that produced by the toxin. Myocytes kept at room temperature (22 degrees C) showed no such evidence of resensitization over periods up to 6h.8. These observations are consistent with the hypothesis that raised catecholamine levels result in increased inhibitory G-protein levels and functional P-adrenoceptor desensitization in heart failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324064      PMCID: PMC1907432          DOI: 10.1111/j.1476-5381.1992.tb14302.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Species dependence of contraction velocity in single isolated cardiac myocytes.

Authors:  S E Harding; P O'Gara; S M Jones; L A Brown; G Vescovo; P A Poole-Wilson
Journal:  Cardioscience       Date:  1990-03

2.  Plasma norepinephrine in congestive heart failure.

Authors:  J A Thomas; B H Marks
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

3.  Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.

Authors:  M B Fowler; J A Laser; G L Hopkins; W Minobe; M R Bristow
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

4.  Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits.

Authors:  C Reithmann; P Gierschik; D Sidiropoulos; K Werdan; K H Jakobs
Journal:  Eur J Pharmacol       Date:  1989-08-15       Impact factor: 4.432

5.  Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function.

Authors:  S M Jones; M S Kirby; S E Harding; G Vescova; R B Wanless; L D Dalla Libera; P A Poole-Wilson
Journal:  Cardiovasc Res       Date:  1990-10       Impact factor: 10.787

6.  Functional and autoradiographic evidence for endothelin 1 receptors on human and rat cardiac myocytes. Comparison with single smooth muscle cells.

Authors:  C J Moody; M R Dashwood; R M Sykes; M Chester; S M Jones; M H Yacoub; S E Harding
Journal:  Circ Res       Date:  1990-09       Impact factor: 17.367

7.  Reduced beta-agonist sensitivity in single atrial cells from failing human hearts.

Authors:  S E Harding; S M Jones; P O'Gara; G Vescovo; P A Poole-Wilson
Journal:  Am J Physiol       Date:  1990-10

8.  The anti-adrenergic effect of adenosine and its blockade by pertussis toxin: a comparative study in myocytes isolated from guinea-pig, rat and failing human hearts.

Authors:  L A Brown; S M Humphrey; S E Harding
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

9.  Reduced positive inotropic effects in diseased human ventricular myocardium.

Authors:  L Brown; B Lorenz; E Erdmann
Journal:  Cardiovasc Res       Date:  1986-07       Impact factor: 10.787

10.  Evidence against spare or uncoupled beta-adrenoceptors in the human heart.

Authors:  R H Schwinger; M Böhm; E Erdmann
Journal:  Am Heart J       Date:  1990-04       Impact factor: 4.749

View more
  20 in total

1.  Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.

Authors:  R I Hussain; F Afzal; H K Mørk; J M Aronsen; I Sjaastad; J-B Osnes; T Skomedal; F O Levy; K A Krobert
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Up-regulation and functional effect of cardiac β3-adrenoreceptors in alcoholic monkeys.

Authors:  Heng-Jie Cheng; Kathleen A Grant; Qing-Hua Han; James B Daunais; David P Friedman; Satoshi Masutani; William C Little; Che-Ping Cheng
Journal:  Alcohol Clin Exp Res       Date:  2010-05-12       Impact factor: 3.455

3.  Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.

Authors:  Ewa Soltysinska; Stefanie Thiele; Søren Peter Olesen; Oleg E Osadchii
Journal:  Pflugers Arch       Date:  2011-08-03       Impact factor: 3.657

Review 4.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 5.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 6.  Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.

Authors:  Anthony Yiu-Ho Woo; Ying Song; Rui-Ping Xiao; Weizhong Zhu
Journal:  Br J Pharmacol       Date:  2014-12-17       Impact factor: 8.739

7.  Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.

Authors:  Joe B Blumer; Kevin Lord; Thomas L Saunders; Alejandra Pacchioni; Cory Black; Eric Lazartigues; Kurt J Varner; Thomas W Gettys; Stephen M Lanier
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling.

Authors:  Susanne Lutz; Roman A Mura; Hans Joerg Hippe; Christiane Tiefenbacher; Feraydoon Niroomand
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

9.  Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.

Authors:  D G Wynne; P A Poole-Wilson; S E Harding
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

10.  Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi.

Authors:  Caroline Bull Melsom; Rizwan Iqbal Hussain; Øivind Ørstavik; Jan Magnus Aronsen; Ivar Sjaastad; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Kurt Allen Krobert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-13       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.